<DOC>
	<DOCNO>NCT01318538</DOCNO>
	<brief_summary>The purpose Stage II randomize controlled behavioral treatment development trial test effectiveness Women 's Recovery Group ( WRG ) relative mixed-gender Group Drug Counseling ( GDC ) demonstrate feasibility implement WRG open-enrollment ( i.e. , roll admission ) group format two clinical site . The Stage II trial aim ( 1 ) investigate effectiveness WRG relative GDC sample woman heterogeneous respect substance use co-occurring psychiatric disorder , ( 2 ) demonstrate feasibility implement WRG open enrollment group format characteristic community treatment program two site .</brief_summary>
	<brief_title>Women 's Recovery Group ( WRG ) Study - A Randomized Controlled Stage II Trial</brief_title>
	<detailed_description>This Stage II trial build Stage I trial compare single-gender WRG mixed-gender GDC demonstrate preliminary support WRG treat woman substance use disorder ( SUDs ) . It hypothesize woman WRG would decrease substance use woman GDC . The GDC chosen comparison group approximate group drug counsel consistent treatment usual within community . The WRG manual-based group therapy woman heterogeneous respect substance dependence , co-occurring psychiatric disorder , trauma history , age stage life . The WRG 12-session structure relapse prevention group therapy utilize cognitive-behavioral approach include gender-specific content single-gender group composition . There 14 specific session topic flexibly implement order 12-week sequence group . In Stage I trial , woman randomize WRG ( n=16 ) mixed-gender GDC ( n =7 ) . No significant difference outcomes emerge WRG GDC 12 week group sequence . However , 6 month post-treatment , WRG participant show pattern continue reduction substance use GDC participant . While design Stage I trial essential treatment development testing , Stage I trial small sample size use semi-closed enrollment format . However , treatment deliver open enrollment format ( i.e. , roll admission ) patient enter time group sequence exit group 12 week complete . Because WRG intend manual-based treatment ready dissemination clinical practice demonstrate effective , Stage II trial design implemented open group format enroll large , diverse sample two clinical site . The study design investigate effectiveness WRG relative GDC ( 1 ) reduce day use substance baseline sample woman heterogeneity regard substance dependence , co-occurring psychiatric disorder , demographic characteristic , ( 2 ) demonstrate feasibility implement WRG open-enrollment group format .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Alcohol-Related Disorders</mesh_term>
	<mesh_term>Ethanol</mesh_term>
	<criteria>Subjects include study : 18 year old use substance within past 60 day meet current Diagnostic Statistical Manual ( DSM ) IV criterion ( American Psychiatric Association , 2000 ; World Health Organization , 1997 ) substance dependence ( addition nicotine dependence ) plan stay within area study period consent study personnel communicate mental health professional receive care furnish names two locator assist study personnel locate study period interested group treatment live close enough either McLean Hospital SSTAR come group weekly able sign inform consent . Patients exclude : current medical condition would prevent regular group attendance mental retardation organic mental disorder certain major Axis I psychiatric disorder accord Composite International Diagnostic Interview ( CIDI ) , psychotic disorder bipolar I disorder would residential treatment set throughout treatment period substance use monitor restrict ( e.g. , therapeutic community ) require medical detoxification ( patient could enter study detoxify ) current intravenous drug user engage selfdestructive behavior ( e.g. , lifethreatening bulimia anorexia , suicide attempt chronic suicidality ) behavior ( e.g. , violence toward others , assault behavior )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Substance use disorder , Gender difference , woman , treatment outcome , group therapy</keyword>
</DOC>